Scientists Create Bacteria That Target and Fight Cancer

Scientists are revolutionizing cancer treatment using [synthetic biology|noun], transforming bacteria into living drug factories.

Traditional treatments like chemotherapy often harm healthy tissue, but engineered bacteria, such as a modified version of the probiotic E. coli, can navigate directly to the low-oxygen cores of solid tumors.

Once they arrive, these bacteria act as specialized delivery vehicles, releasing anticancer drugs exclusively at the site.

This precise targeting minimizes side effects while simultaneously alerting the [immune system|noun] to attack hidden cancer cells.

A notable study from March 2026 demonstrated that this method could deliver the anticancer drug [Romidepsin|noun] effectively in mouse models.

William B.

Coley, modern technology has refined it into a safe, controlled approach.

Researchers are currently addressing significant [challenges|noun], including ensuring the bacteria do not spread to healthy organs and passing stringent safety regulations.

Although still in the early stages of research, these tiny microbial helpers represent a promising future in the fight against cancer, potentially offering a more potent and less toxic alternative to traditional therapies.